Induction of tolerance through mixed chimerism

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 1, 2014, Pages

  Sachs, David H ^a   Kawai, Tatsuo ^a   Sykes, Megan ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; DONOR LYMPHOCYTE INFUSION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; NONHUMAN; PROTEIN EXPRESSION; SPLENECTOMY; SURVIVAL; T CELL DEPLETION; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; ANIMAL; DISEASE MODEL; IMMUNOLOGY; METHODOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW;

ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERISM; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84891811304     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a015529     Document Type: Article

References (139)

1. Adams A.B., Pearson TC, Larsen CP. 2003a. Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 196: 147-160.
2. Adams A.B., Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, et al. 2003b. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111: 1887-1895.
3. Andreola G., Chittenden M, Shaffer J, Cosimi AB, Kawai T, Cotter P., Dey B, Tolkoff-Rubin N, Preffer F, Bonnefoix T, et al. 2011. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/ kidney transplantation. Am J Transplant 11: 1236-1247.
4. Aversa F., Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F., Ruggeri L, Barbabietoloa G, Aristei C, Latini P, et al. 1998. Treatment of high-risk acute leukemia with T cell-depleted stem cells fromrelated donorswith one fully mismatched haplotype. New Engl J Med 339: 1186-1193.
5. Bemelman F., Honey K, Adams E, Cobbold S, Waldmann H. 1998. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol 160: 2645-2648.
6. Bigenzahn S., Blaha P, Koporc Z, Pree I, Selzer E, Bergmeister H, Wrba F, Heusser C, Wagner K, Muehlbacher F, et al. 2005. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 5: 1237-1247.
7. Bonasio R., Scimone ML, Schaerli P, Grabie N, Lichtman AH, von Andrian UH. 2006. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7: 1092-1100.
8. Bordignon C., Keever CA, Small TN, Flomenberg N, Dupont B, O'Reilly RJ, KernanNA. 1989. Graft failure after T-celldepleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood 74: 2237-2243.
9. Buhler L.H., Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B., et al. 2002. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74: 1405-1409.
10. Chakraverty R., Cote D, Buchli J, Cotter P, Hsu R, Zhao G, Sachs T., Psitilides C, Bronson R, Means T, et al. 2006a. An inflammatory checkpoint regulates recruitment of graftversus-host-reactive T cells to peripheral tissues. J Exp Med 203: 2021-2031.
11. Chakraverty R., Eom HS, Sachs J, Buchli J, Cotter P, Hsu R, Zhao G., Sykes M. 2006b. Host MHC class II+ antigenpresenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood 108: 2106-2113.
12. Cina R.A., Wikiel KJ, Lee PW, Cameron AM, Hettiarachy S, Rowland H., Goodrich J, Colby C, Spitzer TR, NevilleDM Jr, et al. 2006. Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation 81: 1677-1685.
13. Cobbold S.P., Qin S, Waldmann H. 1990. Reprogramming the immune system for tolerance with monoclonal antibodies. Sem Immunol 2: 377-387.
14. Cosimi A.B., Sachs DH. 2004. Mixed chimerism and transplantation tolerance. Transplantation 77: 943-946.
15. Davis M.M., Bjorkman PJ. 1990. A model for T cell receptor and MHC/peptide interaction. Adv Exp Med Biol 254: 13-16.
16. Dey B.R., Mcafee S, Colby C, Cieply K, Caron M, Saidman S, Preffer F., Shaffer J, Tarbell N, Sackstein R, et al. 2005. Anti-tumor response despite loss of donor chimerism in patients treated with nonmyeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol 128: 351-359.
17. Domenig C., Sanchez-Fueyo A, Kurtz J, Alexopoulos AP, Mariat C., Sykes M, Strom TB, Zheng XX. 2005. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J Immunol 175: 51-60.
18. Donskoy E., Goldschneider I. 2003. Two developmentally distinct populations of dendritic cells inhabit the adult mouse thymus: Demonstration by differential importation of hematogenous precursors under steady state conditions. J Immunol 170: 3514-3521.
19. + T cells, precluding a role for sustained regulation. Eur J Immunol 35: 2679-2690.
20. Fehr T., Haspot F, Mollov J, Chittenden M, Hogan T, Sykes M. 2008. Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells and MHC class II. J Immunol 181: 165-173.
21. Fehr T., Lucas CL, Kurtz J, Onoe T, Zhao G, Hogan T, Vallot C, Rao A, Sykes M. 2010. A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo. Blood 115: 1280-1287.
22. Fleischhauer K., KernanNA, O'Reilly RJ, Dupont B, Yang SY. 1990. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. New Engl J Med 323: 1818-1822.
23. Fuchimoto Y., Yamada K, Shimizu A, Yasumoto A, Sawada T, Huang C.H., Sachs DH. 1999. Relationship between chimerism and tolerance in a kidney transplantation model. J Immunol 162: 5704-5711.
24. Fuchimoto Y., Huang CA, Yamada K, Shimizu A, Kitamura H, Colvin RB, Ferrara V, Murphy MC, Sykes M, White-Scharf M., et al. 2000. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 105: 1779-1789.
25. Fudaba Y., Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman SL, et al. 2006. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am J Transplant 6: 2121-2133.
26. Guzzetta P.C., Sundt TM, Suzuki T, Mixon A, Rosengard BR, Sachs DH. 1991. Induction of kidney transplantation tolerance across MHC barriers by bone marrow transplantation in miniature swine. Transplantation 51: 862-866.
27. Hadeiba H., Lahl K, Edalati A, Oderup C, Habtezion A, Pachynski R., Nguyen L, Ghodsi A, Adler S, Butcher EC. 2012. Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance. Immunity 36: 438-450.
28. Hanekamp J.S., Duran-Struuck R, Sachs DH. 2011. Transplantation in miniature swine. In The minipig in biomedical research (ed. McAnulty PA), pp. 357-372. Taylor & Francis, London, 2011.
29. Haspot F., Fehr T, Gibbons C, Zhao G, Hogan T, Honjo T, Freeman G.J., Sykes M. 2008. Peripheral deletional tolerance of alloreactive CD8 but not CD4 cells is dependent on the PD-1/PD-L1 pathway. Blood 112: 2149-2155.
30. + T cells. Bone Marrow Transplant 18: 285-292.
31. Haynes B.F., Markert ML, Sempowski GD, Patel DD, Hale LP. 2000. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 18: 529-560.
32. Helg C., Chapuis B, Bolle JF, Morel P, Salomon D, Roux E, Antonioli V., Jeannet M, Leski M. 1994. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 58: 1420-1422.
33. Horner B.M., Cina RA, Wikiel KJ, Lima B, Ghazi A, Lo DP, Yamada K., Sachs DH, Huang CA. 2006. Predictors of organ allograft tolerance following hematopoietic cell transplantation. Am J Transplant 6: 2894-2902.
34. Huang C.A., Lorf T, Arn JS, Koo GC, Blake T, Sachs DH. 1999a. Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation 6: 201-212.
35. Huang C.A., Yamada K, Murphy MC, Shimizu A, Colvin RB, Neville D.M.J., Sachs DH. 1999b. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9. Transplantation 68: 855-860.
36. Huang C.A., Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville D.M.J., Sachs DH. 2000. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 105: 173-181.
37. Ildstad S.T., Sachs DH. 1984. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307: 168-170.
38. Ildstad S.T., Wren SM, Bluestone JA, Barbieri SA, Sachs DH. 1985. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 162: 231-244.
39. Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, StephanyD, Sachs DH. 1986. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10. D2! B10). J Immunol 136: 28-33.
40. Ito H., Kurtz J, Shaffer J, Sykes M. 2001. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 L interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. J Immunol 166: 2970-2981.
41. Jacobsen N., Taaning E, Ladefoged J, Kristensen JK, Pedersen FK. 1994. Tolerance to an HLA-B, DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 343: 800.
42. Kasamon Y.L., Luznik L, Leffell MS, Kowalski J, Tsai HL, Bolanos-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N., et al. 2010. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: Effect of HLA disparity on outcome. Biol Blood Marrow Transplant 16: 482-489.
43. Kaufman C.L., Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST. 1994. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84: 2436-2446.
44. Kawai T., Cosimi AB, Colvin RB, Powelson J, Eason J, Kozlowski T, Sykes M, Monroy R, Tanaka M, Sachs DH. 1995. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 59: 256-262.
45. Kawai T., Poncelet A, Sachs DH, Mauiyyedi S, Boskovic S, Wee S.L., Ko DS, Bartholomew A, Kimikawa M, Hong HZ, et al. 1999. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68: 1767-1775.
46. Kawai T., Andrews D, Colvin RB, Sachs DH, Cosimi AB. 2000. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand [letter]. Nat Med 6: 114.
47. Kawai T., Sogawa H, Koulmanda M, Smith RN, O'Neil JJ, Wee S.L., Boskovic S, Sykes M, Colvin RB, Sachs DH, et al. 2001. Long-term islet allograft function in the absence of chronic immunosuppression: A case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation 72: 351-354.
48. Kawai T., Cosimi AB, Wee SL, Houser S, Andrews D, Sogawa H, Phelan J, Boskovic S, Nadazdin O, Abrahamian G, et al. 2002. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 73: 1757-1764.
49. Kawai T., Sogawa H, Boskovic S, Abrahamian G, Smith RN, Wee S.L., Andrews D, Nadazdin O, Koyama I, Sykes M, et al. 2004. CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant 4: 1391-1398.
50. Kawai T., Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V., et al. 2008. HLA-mismatched renal transplantation without maintenance immunosuppression. New Engl J Med 358: 353-361.
51. Kawai T., Cosimi AB, Sachs DH. 2011. Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr Opin Organ Transplant 16: 366-371.
52. Kean L.S., Blazar BR. 2012. Cooking up tolerance: Has a new recipe been created? Am J Transplant 12: 1667-1669.
53. Kernan N.A., Flomenberg N, Dupont B, O'Reilly RJ. 1987. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Transplantation 43: 842-847.
54. Khan A., Tomita Y, Sykes M. 1996. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 62: 380-387.
55. Kimikawa M., Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. 1997. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 64: 709-716.
56. Kohrt H.E., Turnbull BB, Heydari K, Shizuru JA, Laport GG, Miklos D.B., Johnston LJ, Arai S, Weng WK, Hoppe RT, et al. 2009. TLI and ATGconditioningwith low risk of graftversus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 114: 1099-1109.
57. Koyama I., Nadazdin O, Boskovic S, Ochiai T, Smith RN, Sykes M., Sogawa H, Murakami T, Strom TB, Colvin RB, et al. 2007. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 7: 1055-1061.
58. Kraus A.B., Shaffer J, Toh HC, Preffer F, Dombkowski D, Saidman S., Colby C, George R, Mcafee S, Sackstein R, et al. 2003. Early host CD8 T-cell recovery and sensitized anti-donor IL-2-producing and cytolytic T-cell responses associated with marrow graft rejection following nonmyeloablative bone marrow transplantation. Exp Hematol 31: 609-621.
59. + cells. Am J Transplant 1: 339-349.
60. Kurtz J., Shaffer J, Anosova N, Benichou G, Sykes M. 2004. Mechanisms of early peripheral CD4 T cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: Evidence for anergy and deletion, but not regulatory cells. Blood 103: 4336-4343.
61. Larsen C.P., Page A, Linzie KH, Russell M, Deane T, Stempora L, Strobert E, Penedo MC, Ward T, Wiseman R, et al. 2010. An MHC-defined primate model reveals significant rejection of bone marrow after mixed chimerism induction despite full MHC matching. Am J Transplant 10: 2396-2409.
62. Leventhal J., Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud D.J., King B, Elliott MJ, Herzig G, Herzig R, et al. 2012. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 4: 124ra28.
63. Leventhal J., Abecassis M, Miller J, Gallon L, Tollerud D, Elliott M.J., Bozulic LD, Houston C, Sustento-Reodica N, Ildstad ST. 2013. Tolerance induction inHLAdisparate living donor kidney transplantation by donor stem cell infusion: Durable chimerism predicts outcome. Transplantation 95: 169-176.
64. Li H.W., Sykes M. 2012. Emerging concepts in haematopoietic cell transplantation. Nat Rev Immunol 12: 403-416.
65. Li H.W., Sachs J, Pichardo C, Bronson R, Zhao G, Sykes M. 2012. Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli. J Immunol 189: 5572-5581.
66. Locascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman SL, Spitzer T.R., et al. 2010. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation 90: 1607-1615.
67. Lowsky R., Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, et al. 2005. Protective conditioning for acute graft-versus-host disease. N Engl J Med 353: 1321-1331.
68. Lucas CL, Workman CJ, Beyaz S, Locascio S, Zhao G, Vignali DA, Sykes M. 2011. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 Tcell tolerance induced by allogeneic BMT with anti-CD40 L. Blood 117: 5532-5540.
69. Lunney J.K., Pescovitz MD. 1987. Phenotypic and functional characterization of pig lymphocyte populations. Vet Immunol Immunopathol 17: 135-144.
70. Lunney J.K., Sachs DH. 1995. The swine leukocyte antigen (SLA) complex. In Transplantation immunology (ed. Bach F.H., Auchincloss Jr H), pp. 339-345. Wiley, New York.
71. Luznik L., O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M., Gooley TA, Piantadosi S, Kaup M, Ambinder RF, et al. 2008. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14: 641-650.
72. Manilay J.O., Pearson DA, Sergio JJ, Swenson KG, Sykes M. 1998. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 66: 96-102.
73. Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, Sykes M. 2002. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: A critical role for host antigen-presenting cells. Blood 100: 1903-1909.
74. MaparaMY, Kim YM, Marx J, Sykes M. 2003. DLI-mediated GVL effects in mixed chimeras established with a nonmyeloablative conditioning regimen: Extinction of GVL effects coincides with loss of alloreactive cells following conversion to full donor chimerism. Transplantation 76: 297-305.
75. Martin P.J., Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P., Appelbaum FR, Clift R, Fefer A, Witherspoon RP, et al. 1985. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66: 664-672.
76. Martin P.J., Hansen JA, Torok-Storb B, Durnam D, Przepiorka D, O'Quigley J, Sanders J, Sullivan KM, Witherspoon RP, Deeg HJ, et al. 1988. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 3: 445-456.
77. Mezrich J., Yamada K, Sachs DH, Madsen JC. 2004. Regulatory T cells generated by the kidney may mediate the beneficial immune effects of combining kidney with heart transplantation. Surgery 135: 473-478.
78. Millan MT. 2005. Studies of tolerance and chimerism after combined blood stem cell and kidney transplantation in humans. Am J Transplant 5(Suppl): 544.
79. Millan M.T., Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling J.D., Grumet FC, Tan JC, Salvatierra O, Hoppe RT, Strober S. 2002. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 73: 1386-1391.
80. + T cell tolerance. Am J Transplant 10: 518-526.
81. Nadazdin O, Boskovic S, Murakami T, O'Connor DH, Wiseman RW, Karl JA, Tuscher JJ, Sachs DH, Madsen JC, Tocco G., et al. 2010. Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant 10: 1375-1384.
82. Nash K., Chang Q, Watts A, Treter S, Oravec G, Ferrara V, Buhler L., Basker M, Gojo S, Sachs DH, et al. 1999. Peripheral blood progenitor cell mobilization and leukapheresis in pigs. Lab Anim Sci 49: 645-649.
83. Neville D.M.J., Scharff J, Hu HZ, Rigaut K, Shiloach J, Slingerland W, Jonker M. 1996. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9. J Immunother Emphasis Tumor Immunol 19: 85-92.
84. Nikolic B., Khan A, Sykes M. 2001. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: The importance of overcoming intrathymic alloresistance. Biol Blood Marrow Transplant 7: 144-153.
85. Pelot M.R., Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M. 1999. Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based non-myeloablative conditioning regimen. Biol Blood Marrow Transplant 5: 133-143.
86. Pennington L.R., Lunney JK, Sachs DH. 1981. Transplantation in miniature swine. VIII. Recombination within the major histocompatibility complex of miniature swine. Transplantation 31: 66-71.
87. Pennington L.R., Sakamoto K, Popitz-Bergez FA, Pescovitz MD, McDonough MA, MacVittie TJ, Gress RE, Sachs DH. 1988. Bone marrow transplantation in miniature swine. I: Development of the model. Transplantation 45: 21-26.
88. Pescovitz M.D., Sachs DH, Lunney JK, Hsu SM. 1984a. Localization of class II MHC antigens on porcine renal vascular endothelium. Transplantation 37: 627-630.
89. Pescovitz MD, Thistlethwaite JR Jr, AuchinclossHJr, Ildstad ST, Sharp TG, Terrill R, Sachs DH. 1984b. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med 160: 1495-1508.
90. Pescovitz M.D., Hsu SM, Katz SI, Lunney JK, Shimada S, Sachs Dh. 1990. Characterization of a porcine CD1-specific mAb that distinguishes CD4/CD8 double-positive thymic from peripheral T lymphocytes. Tissue Antigens 35: 151-156.
91. Pescovitz M.D., Book BK, Aasted B, Dominguez J, Ezguerra A, Trebichavsky I, Novikov B, Valpotic I, Neilson J, Arn S, et al. 1998. Analyses of monoclonal antibodies reacting with porcine CD3: Results from the Second International Swine CD Workshop. Vet Immunol Immunopathol 60: 261-268.
92. Popitz-Bergez FA, Sakamoto K, Pennington LR, Pescovitz MD, McDonough MA, MacVittie TJ, Gress RE, Sachs DH. 1988. Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival. Transplantation 45: 27-31.
93. Porcheray F, WongW, Saidman SL, De Vito J, Girouard TC, Chittenden M., Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, et al. 2009. B-cell immunity in the context of Tcell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant 9: 2126-2135.
94. Proietto A.I., van Dommelen S, Zhou P, Rizzitelli A, D'Amico A, Steptoe RJ, Naik SH, Lahoud MH, Liu Y, Zheng P, et al. 2008. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci 105: 19869-19874.
95. Rubio M.T., Kim YM, Sachs T, Mapara M, Zhao G, Sykes M. 2003. Anti-tumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: Critical role for recipient-derived IFN-γ. Blood 102: 2300-2307.
96. + T cells. J Immunol 175: 665-676.
97. Rubio M.T., Zhao G, Buchli J, Chittenden M, Sykes M. 2006. Role of indirect allo-and autoreactivity in anti-tumor responses induced by recipient leukocyte infusions (RLI) in mixed chimeras prepared with nonmyeloablative conditioning. Clin Immunol 120: 33-44.
98. Sachs DH. 1992. MHC homozygous miniature swine. In Swine as models in biomedical research (ed Swindle MM, et al.), pp. 3-15. Iowa State University Press, Ames, IA.
99. Sachs DH. 1994. The pig as a potential xenograft donor. Vet Immunol Immunopathol 43: 185-191.
100. Sachs DH. 2003. Tolerance: Of mice and men. J Clin Invest 111: 1819-1821.
101. Saito T.I., Rubio MT, Sykes M. 2006. Clinical relevance of recipient leukocyte infusion as antitumor therapy following nonmyeloablative allogeneic hematopoietic cell transplantation. Exp Hematol 34: 1271-1277.
102. Sakamoto K., Pennington LR, Popitz-Bergez FA, Pescovitz MD, Gress RE, McDonough MA, Shimada S, Katz SI, Sachs DH. 1987. Swine GVHD model and the effect of T cell depletion of marrow by monoclonal antibodies. Prog Bone Marrow Transplant 449-453.
103. Sakamoto K., Sachs DH, Shimada S, Popitz-Bergez FA, Pennington LR, Pescovitz MD, McDonough MA, MacVittie TJ, Katz SI, Gress RE. 1988. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow. Transplantation 45: 869-875.
104. Sayegh M.H., Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL. 1991. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114: 954-955.
105. Scandling J.D., Busque S, Dejbakhsh-Jones S, Benike C, Millan M.T., Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S. 2008. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358: 362-368.
106. Scandling J.D., Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, Shizuru JA, Lowsky R, Engleman EG, Strober S. 2012. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 12: 1133-1145.
107. + lymphocytes using a mousehuman chimeric monoclonal antibody. Am J Pathol 154: 1923-1932.
108. Seidl C., Saraiya C, Osterweil Z, Fu YP, Lee JS. 1992. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J Immunol 148: 1576-1584.
109. Shaffer J., Villard J, Means TK, Alexander S, Dombkowski D, Dey B.R., McAffee S, Ballen KK, Saidman S, Preffer FI, et al. 2007. Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol 35: 1140-1152.
110. Sharabi Y., Sachs DH. 1989. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 169: 493-502.
111. Sharabi Y., Sachs DH, Sykes M. 1992. T cell subsets resisting induction of mixed chimerism across various histocompatibility barriers. In Progress in immunology. VIII. Proceedings of the Eighth International Congress of Immunology, Budapest (ed. Gergely J, et al.), pp. 801-805. Springer-Verlag, Heidelberg.
112. Slavin S., Strober S, Fuks Z, Kaplan HS. 1977. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: Long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 146: 34.
113. Slavin S., Gottlieb M, Strober S, Bieber C, Hoppe R, Kaplan HS, Grumet FC. 1979. Transplantation of bone marrow in outbred dogs without graft-versus-host disease using total lymphoid irradiation. Transplantation 27: 139-142.
114. Smith C.V., Suzuki T, Guzzetta PC, Nakajima K, Sundt TM, Mixon A., Spitzer TR, Eckhaus M, Sachs DH. 1993. Bone marrow transplantation in miniature swine: IV. Development of myeloablative regimens that allow engraftment across major histocompatibility barriers. Transplantation 56: 541-549.
115. Spitzer TR. 2001. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27: 893-898.
116. Spitzer T.R., Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs DH, Cosimi AB. 1999. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 68: 480-484.
117. Spitzer T.R., Mcafee S, Dey BR, Colby C, Hope J, Grossberg H, Preffer F, Shaffer J, Alexander SI, Sachs DH, et al. 2003. Non-myeloablative haploidentical stem cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. Transplantation 75: 1748-1751.
118. Spitzer T.R., Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey B.R., Ballen K, Delmonico F, Saidman S, Sachs DH, et al. 2011. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with endstage renal disease. Transplantation 91: 672-676.
119. Strober S., Dhillon M, Schubert M, Holm B, Engleman E, Benike C., Hoppe R, Sibley R, Myburgh JA, Collins G, et al. 1989. Acquired immune tolerance to cadaveric renal allografts: A study of three patients treated with total lymphoid irradiation. N Engl J Med 321: 28-33.
120. Strober S., Lowsky RJ, Shizuru JA, Scandling JD, Millan MT. 2004. Approaches to transplantation tolerance in humans. Transplantation 77: 932-936.
121. Strober S., Spitzer TR, Lowsky R, Sykes M. 2011. Translational studies in hematopoietic cell transplantation: Treatment of hematologic malignancies as a stepping stone to tolerance induction. Semin Immunol 23: 273-281.
122. Sundt TM III, Suzuki T, Kortz O, Eckhaus ME, Gress RE, Sachs DH. 1988. Induction of specific transplant tolerance in a large animal model by bone marrow transplantation. Surgical Forum 39: 365-367.
123. Sykes M., Sachs DH. 1988. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today 9: 23-27.
124. Sykes M., Sachs DH. 2001. Mixed chimerism. Philos Trans R Soc Lond B Biol Sci 356: 707-726.
125. Sykes M., Sheard MA, Sachs DH. 1988. Graft-versus-hostrelated immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells. J Exp Med 168: 2391-2396.
126. + T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40 L. Am J Transplant 4: 31-40.
127. Tomita Y., Khan A, Sykes M. 1994. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantion in mice conditioned with a non-myeloablative regimen. J Immunol 153: 1087-1098.
128. Tomita Y., Khan A, Sykes M. 1996a. Mechanism by which additional monoclonal antibody injections overcome the requirement for thymic irradiation to achieve mixed chimerism in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 61: 477-485.
129. Tomita Y., Sachs DH, Khan A, Sykes M. 1996b. Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 61: 469-477.
130. Tonsho M. 2012. Induction of tolerance to heart allografts by donor kidney co-transplantation in nonhuman primates (NHPs). American Transplant Congress 2012 Conference Proceedings, Boston, p. 157.
131. Vallera D.A., Taylor PA, Sprent J, Blazar BR. 1994. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice. Transplantation 57: 249-256.
132. Valujskikh A., Fedoseyeva E, Benichou G, Heeger PS. 2002. Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 73: 1130-1137.
133. Weiden P.L., Sullivan KM, Flournoy N, Storb R, Thomas ED. 1981. Antileukemic effect of chronic graft-versus-host disease. New Engl J Med 304: 1529-1533.
134. Wekerle T., Sayegh MH, Hill J, Zhao Y, Chandraker A, Swenson KG, Zhao G, Sykes M. 1998. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 187: 2037-2044.
135. Wekerle T., Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J., Sayegh MH, Sykes M. 2000. Allogeneic bone marrow translantation with costimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6: 464-469.
136. Williams RC Jr. 1988. Hypothesis: Rheumatoid factors are antiidiotypes related to bacterial or viral Fc receptors. Arthritis Rheum 31: 1204-1207.
137. Wu Z., Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, Markmann J.F., Kassaee A, Rosengard BR, Hancock WW, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 10: 87-92.
138. Yamada Y., Boskovic S, Aoyama A, Murakami T, Putheti P, Smith R.N., Ochiai T, Nadazdin O, Koyama I, Boenisch O, et al. 2012. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant 12: 330-340.
139. Zinkernagel R.M., Althage A, Callahan G, WelshRMJr. 1980. On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol 124: 2356-2365.